Asclera (Merz North America, Inc)
Welcome to the PulseAid listing for the Asclera drug offered from Merz North America, Inc. This Sclerosing Agent [EPC],Sclerosing Activity [MoA],Vascular Sclerosing Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merz North America, Inc |
| NON-PROPRIETARY NAME: | POLIDOCANOL |
| SUBSTANCE NAME: | POLIDOCANOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Sclerosing Agent [EPC],Sclerosing Activity [MoA],Vascular Sclerosing Activity [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-06-01 |
| END MARKETING DATE: | 0000-00-00 |
Asclera HUMAN PRESCRIPTION DRUG Details:
| Item Description | Asclera from Merz North America, Inc |
| LABELER NAME: | Merz North America, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.005(g/mL) |
| START MARKETING DATE: | 2010-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 46783-121_5713eeed-db88-4e10-8ef1-baca3ca8c8ed |
| PRODUCT NDC: | 46783-121 |
| APPLICATION NUMBER: | NDA021201 |
Other POLIDOCANOL Pharmaceutical Manufacturers / Labelers:
